Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study - Wikidata - wikimedia - TriplyDB

Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study

Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study

http://www.wikidata.org/entity/Q33629092

about

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor Simeprevir and frequently used concomitant medications.Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational study Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African-American patients: a community-based retrospective cohort study

P2860

Q47551957-F77362AE-8A2A-487B-BA8B-08CACCD205D5 Q56398253-DF9E8C15-7EA0-463E-B6B9-6A16420AF411 Q57841241-DE042AB1-32F1-4FE9-8802-BE1D3BD6E7DF

P2860

Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study

http://www.wikidata.org/entity/Q33629092

description

2016 nî lūn-bûn

@nan

2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Real-World Effectiveness of Si ...... titis C Virus: The SONET Study

@ast

Real-World Effectiveness of Si ...... titis C Virus: The SONET Study

@en

type

label

Real-World Effectiveness of Si ...... titis C Virus: The SONET Study

@ast

Real-World Effectiveness of Si ...... titis C Virus: The SONET Study

@en

prefLabel

Real-World Effectiveness of Si ...... titis C Virus: The SONET Study

@ast

Real-World Effectiveness of Si ...... titis C Virus: The SONET Study

@en

P1433

Q33629092-EAABDBE0-A75C-4061-A027-3EB9F6F31CCC

P1476

Q33629092-61F9938F-3A25-406B-8C27-3E4EE6251049

P2093

Q33629092-02848579-0357-4142-8789-F6B63D5A62C7

Q33629092-090054FF-8C20-4A9F-90E7-25C46A8C5E0A

Q33629092-0F0AC2EC-5AD9-4E80-A4E2-AF0E9E77588A

Q33629092-16C8A038-4FBE-4B02-B8DB-BF9F5B9D2628

Q33629092-310127A9-F916-4F25-90EE-1DFF96542FF0

Q33629092-39AD6F62-2132-408F-9877-B9C09ED33347

Q33629092-3E9A5E63-EA74-4B4B-B779-2A04F265ED9A

Q33629092-51E95EB7-7A18-4C47-BEC5-49D1F7132ADA

Q33629092-5493C566-3127-4946-BF68-F12003B28128

Q33629092-7F43E661-A44C-4F93-8A22-450C6CFD14EA

P2860

Q33629092-01BE3C23-8194-4E6E-B4CA-BE2C95C23D12

Q33629092-13C4FB8B-E2BA-4544-86B6-43BD72D44CCB

Q33629092-14111C6E-3447-4535-A7E4-BB57CA7568C4

Q33629092-177D1764-1DD7-4C27-A4C9-3532894F11C4

Q33629092-22F02DD8-46E5-41D0-BD5F-B8AFBBC03FF1

Q33629092-27D76AC3-5926-43A1-B9C0-1F70E5F544A8

Q33629092-31FCB0E9-F909-41FB-A6AA-E3FA66CCEF6B

Q33629092-3FAE89B5-EF48-41A8-9EB6-6C0BEF5B13C7

Q33629092-4043E43E-BDF9-4A93-B12C-E79AEF7EEEA4

Q33629092-6445B116-69DC-42E8-88ED-64BD9D93A31E

P304

Q33629092-851DD480-69CC-47E8-9490-0B06F5EE751A

P31

Q33629092-73E051AF-5B7B-4CBA-B36E-B11E88FA0A1B

P356

Q33629092-314EB0B9-71E3-4248-B396-B8EC7B66D14F

P433

Q33629092-56E6F772-6CD2-4B9F-B7DA-DCDECC371664

P478

Q33629092-839A5DC2-0C91-4288-ACB1-6924B93C0DFC

P577

Q33629092-DC9137C0-1783-4740-A2EA-43E11544B9A1

P698

Q33629092-D465B851-E2F7-4E13-B151-87A125F6A391

P932

Q33629092-CC0A159F-7AAF-4C18-855D-888A89606097

P356

P1433

Open forum infectious diseases

P1476

Real-World Effectiveness of Si ...... titis C Virus: The SONET Study

@en

P2093

Avinash Prabhakar

http://www.w3.org/2001/XMLSchema#string

Cynthia Donovan

http://www.w3.org/2001/XMLSchema#string

Imtiaz Alam

http://www.w3.org/2001/XMLSchema#string

Jamie Forlenza

http://www.w3.org/2001/XMLSchema#string

Jihad Slim

http://www.w3.org/2001/XMLSchema#string

Kimberley Brown

http://www.w3.org/2001/XMLSchema#string

Kris Lauwers

http://www.w3.org/2001/XMLSchema#string

Mitchell A Mah'moud

http://www.w3.org/2001/XMLSchema#string

Neeta Tandon

http://www.w3.org/2001/XMLSchema#string

Ralph DeMasi

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis

Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals.

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2)

Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.

Examining the clinical course of genotype 1 chronic hepatitis C patients treated with the cosmos regimen: including patients with advanced liver disease and East Asian ancestry.

Lower response to simeprevir and sofosbuvir in HCV genotype 1 in routine practice compared with clinical trials.

Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans.

Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.

Modeling the effect of HIV coinfection on clearance and sustained virologic response during treatment for hepatitis C virus.

P304

ofw258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFW258

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28480251

http://www.w3.org/2001/XMLSchema#string

P932

5413999

http://www.w3.org/2001/XMLSchema#string